J3-2359 — Annual report 2009
1.
Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008)

The main conclusion is that systems biology approaches can indeed advance cancer research, having already proved successful in a very wide variety of cancer-related areas, and are likely to prove superior to many current research strategies.

COBISS.SI-ID: 7025236
2.
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer

Trastuzumab shows clinical activity in human epidermal growth factor receptor 2 (HER-2)–positive early and advanced breast cancer. In the German Breast Group 26/Breast International Group 03-05 trial, we investigated if trastuzumab treatment should be continued beyond progression. Continuation of trastuzumab plus capecitabine showed a significant improvement in overall response and time to progression compared with capecitabine alone in women with HER-2–positive breast cancer who experienced progression during trastuzumab treatment

COBISS.SI-ID: 25802969